|When examining the
OBT in the Subjects who were Treatment Failures:
|•28% of treatment failure subjects had no susceptible drugs
at baseline. There was no difference
between the MVC and placebo treatment arms.
|•When looking at changes in susceptibility to OBT on
therapy, 43% of treatment failure subjects lost susceptibility to drugs in
their OBT on treatment and again there was no difference between treatment